The Geniohyoid Muscle in Critical Illness
Assessing the Feasibility and Reliability of an Ultrasound-based Method of Measuring the Geniohyoid Muscle in Mechanically Ventilated Patients - an Observational Study
Many patients lose muscle due to being unwell in an intensive care unit. This muscle loss can lead to weakness of the arms and legs when they leave the unit, and when they go home. For many years investigators have measured the size of these arm and leg muscles using an ultrasound machine, to take a picture of the muscles.
It is also known that patients who are on a ventilator (or "breathing machine") often have problems swallowing when the breathing tube is removed from their mouth. This may be because the muscles of swallowing may also shrink. One of these muscles sits under the jaw and can be measured with ultrasound - the method has been shown to be accurate and reliable in awake volunteers, but these volunteers are usually sat upright in a chair with their mouth closed.
Before it can be assed whether these muscles get smaller, it is needed to assess whether the chosen method is suitable in patients on a ventilator; these patients are lying in bed, and their mouths are open slightly due to the breathing tube.
Proposed Method
This investigation will measure the size of a muscle under the jaw (called the geniohyoid muscle) in patients who are sedated and have a breathing tube in their mouth connected to a ventilator.
Using a normal hospital ultrasound machine, one researcher will place the ultrasound probe under the patient's jaw. When the researcher is happy the probe is in the right place, they will take a picture of the muscle and measure its size and thickness. After a short break, the researcher will repeat this process. After a second short break, another researcher who did not watch the first researcher will also place the probe under the jaw and take a picture of the muscle.
These measurements can be used to to answer the following questions:
- How many patients scanned produced images that could be measured?
- How consistent are the measurements if one person measures the same muscle twice?
- If two people measure the same muscle, do their measurements agree with each other?
The patients will be under sedation when they take part in the study. Because of this, they cannot consent to take part in the study. The patient's next of kin or carer would advise on whether the patient would want to take part. When the patient is awake and has the breathing tube removed, the research team would ask them to sign a consent form to use their data.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Introduction
Many patients who are mechanically ventilated due to critical illness have difficulty in swallowing after the endotracheal tube is removed, a phenomenon known as Post Extubation Dsyphagia (PED). Although multifactorial, atrophy of the swallowing muscles is a potential cause.
Ultrasound is a commonly used investigative modality for the measurement of muscles in critically unwell patients. Measurements can be performed repeatedly over time to track changes in muscle size during the course of a patient's admission. In critically unwell patients, much of the research is focussed on muscles of the limbs and trunk. The muscles of swallowing have been measured using ultrasound, but in awake patients adopting an optimal seated position. Critically unwell patients are bedbound, and the endotracheal tube leaves their mouth in an open position. Before embarking on a study using ultrasound to attempt to track changes in muscle size in the muscles of swallowing, the investigators first wish to assess if such a method is both feasible and reliable.
Methods
Critically unwell patients who are sedated and mechanically ventilated will be recruited into the study after discussion with a patient's personal consultee. The geniohyoid (GH) muscle will be scanned in both the coronal and sagittal planes. The patient will be scanned three times. Twice by one assessor, and once by a second assessor. Cross sectional areas (CSA) of GH will be measured at a later time using image processing software (ImageJ, NIH, USA). Echogenicity, a measurement of the brightness of muscle on ultrasound, will also be assessed.
Results
The primary outcome is to obtain the proportion of patients whose images from ultrasound can provide satisfactory measurement data, in each plane. Furthermore, we will assess the repeatability of each measurement by calculating the intra-rater agreement, and the inter-rater agreement to assess agreement between assessors. An estimate of the mean CSA in each plane will be calculated.
Conclusions
This preliminary data will give us an estimate of the proportion of patients who can provide satisfactory images of GH, in preparation for a larger study assessing longitudinal changes in CSA. Further, the study will give data on both the inter- and intra-rather agreement of the method.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Luoghi di studio
-
-
-
Warrington, Regno Unito, WA5 1QG
- Intensive Care Unit
-
Contatto:
- Peter Turton, MBChB (Hons) MPhil FRCA FFICM
- Numero di telefono: 5594 01925 635911
- Email: peter.turton1@nhs.net
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
· Mechanically ventilated patient on the intensive care unit
- Endotracheal tube via the mouth in-situ (size 7.0 and above)
- Can be recruited at any time during their admission
Exclusion Criteria:
· Ventilated via a nasal endotracheal tube
- Ventilated via a tracheostomy
- Ventilated via a micro-endotracheal tube
- Any previous or active history of head and neck cancer
- Any previous head and neck surgery (excluding tonsillectomy and adenoidectomy)
- Any cranio-facial deformity that would render access to the jaw difficult, including but not limited to short thymo-mental distance
- Any neuromuscular disorder, including previous stroke
- Any previous history of dysphagia or swallowing disorder
- Pregnant patients
- Patients under 18 years of age
- Agitation or movement that would make measurement difficult or inaccurate
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Mechanically ventilated patient group
Any eligible patient who is being mechanically ventilated in the site's intensive care unit, via an endotracheal tube.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Satisfactory image acquisition of the geniohyoid muscle in the coronal plane (n, proportion)
Lasso di tempo: Day 1 (patients are only on the day of the ultrasound)
|
To obtain an estimate for the proportion of patients in which satisfactory images can be measured, in both measured planes (coronal and sagittal views).
An "unsatisfactory" image is due to either the investigator being unable to adequately visualise the GH muscle with the probe (e.g.
due to subcutaneous fat, difficult patient positioning, or when an image has been obtained, the offline CSA measurement cannot be performed due to inadequate visualisation of the muscle's fascial border.
In addition, the co-efficient of variance of the three images taken must be less than 5%.
|
Day 1 (patients are only on the day of the ultrasound)
|
|
Satisfactory image acquisition of the geniohyoid muscle, sagittal plane (n, proportion)
Lasso di tempo: Day 1 - patients are only in the study on the day of the ultrasound scan
|
To obtain an estimate for the proportion of patients in which satisfactory images can be measured, in the sagittal plane.
An "unsatisfactory" image is due to either the investigator being unable to adequately visualise the GH muscle with the probe (e.g.
due to subcutaneous fat, difficult patient positioning, or when an image has been obtained, the offline CSA measurement cannot be performed due to inadequate visualisation of the muscle's fascial border.
In addition, the co-efficient of variance of the three images taken must be less than 5%.
|
Day 1 - patients are only in the study on the day of the ultrasound scan
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Intra-rater agreement, cross sectional area of geniohyoid muscle, coronal plane
Lasso di tempo: Day 1
|
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the coronal plane.
After a short break, a second set of 3 images (set B) will be taken.
Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and B, and calculating the intra-class correlation co-efficient for consistency.
|
Day 1
|
|
Intra-rater agreement, cross sectional area of geniohyoid muscle, sagittal plane
Lasso di tempo: Day 1
|
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the sagittal plane.
After a short break, a second set of 3 images (set B) will be taken.
Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and B, and calculating the intra-class correlation co-efficient for consistency.
|
Day 1
|
|
Inter-rater agreement, cross sectional area of geniohyoid muscle, coronal plane
Lasso di tempo: Day 1
|
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the coronal plane.
After a short break, investigator B will take a second set of 3 images (set C) Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and C, and calculating the intra-class correlation co-efficient for agreement.
|
Day 1
|
|
Inter-rater agreement, cross sectional area of geniohyoid muscle, sagittal plane
Lasso di tempo: Day 1
|
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the coronal plane.
After a short break, investigator B will take a second set of 3 images (set C) Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and C, and calculating the intra-class correlation co-efficient for agreement.
|
Day 1
|
|
Intra-rater agreement, echogenicity of the geniohyoid muscle, sagittal plane
Lasso di tempo: Day 1
|
Investigator A will have taken 2 sets of 3 images (sets A and B) of the geniohyoid muscle in the sagittal plane.
Echogenicity will be measured offline using appropriate imaging software (Image J, NIH) and compared by mean and standard deviation, and by intra-class correlation coefficient for consistency.
|
Day 1
|
|
Inter-rater agreement, echogenicity of the geniohyoid muscle, sagittal plane
Lasso di tempo: Day 1
|
Investigator A will have taken 2 sets of 3 images (sets A and B) of the geniohyoid muscle in the sagittal plane, and investigator B will take set of 3 images (set C).
Echogenicity will be measured offline using appropriate imaging software (Image J, NIH) and compared by mean and standard deviation, and by intra-class correlation coefficient for absolute agreement.
|
Day 1
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- W0001
- 26/NW/0011 (Altro identificatore: REC - North West Greater Manchester South)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Periodo di condivisione IPD
Criteri di accesso alla condivisione IPD
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .